Skip to main content
. 2019 May 20;20(10):2488. doi: 10.3390/ijms20102488

Table 1.

GPCRs modulating TRPV1 function.

GPCR Ligand Involved GPCR Pathway Effect on TRPV1 Reference
Bradykinin B2 Gαq-DAG-PKC increased current [2,41]
Serotonin 5-HT2 Gαq-DAG-PKC increased current [42,43,44]
5-HT4 Gαs-AC-PKA increased current [43]
5-HT7 Gαs-AC-PKA increased current [42]
UTP P2Y2 Gαq-DAG-PKC increased current [45,46,47]
BAM 8-22 MRGPRX1 Gαq-DAG-PKC-PIP2 increased current [48]
Proteases PAR2 Gαq-PKC increased current [49,50]
PAR1 Gαq-PKC increased current [51]
PAR4 Gαq-PKC increased current [51]
PGE2 EP1 Gαq-PKC increased current [52]
EP2 Gαs-PKA increased current [52,53,54]
PGI2 IP Gαq-PKC increased current [52]
IP Gαs-PKA increased current [52]
Endothelin-1 ETA Gαq -PKC increased current [55,56]
Substance P NK1 Gαq -PKCϵ increased current [57]
NK2 Gαq-PKC increased current [58]
H+ TDAG8 (GPR65) Gαs-PKA increased current [59]
Morphine MOP Gαi-reduced AC decreased current [60,61]
Endocannabinoids CB1 Gαi-reduced AC decreased current [62]
CB2 Gαi-reduced AC decreased current [63]

AC, adenylyl cylcase; DAG, diacylglycerol; PKA, proteinkinase A; PKC, protein kinase C; BAM 8–22, bovine adrenal medulla peptide 8–22.